In contrast, the administration of S. boulardii significantly upregulated SIRT1 expression, suggesting that the probiotic may contribute to improved lipid metabolism and reduction in oxidative stress and inflammation, ultimately protecting against the progression of NAFLD. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.